Conexeu Sciences, Inc. engages in the development of regenerative biomaterials needed in wound care, dentistry, and aesthetics. The company was founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell on November 2, 2022 and is headquartered in Reno, NV.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
4
Frequently Asked Questions
What is Market Cap of Conexeu Sciences Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Conexeu Sciences Inc. market cap is $274.01M.
What is the 52-week high for Conexeu Sciences Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Conexeu Sciences Inc. 52 week high is $18.79 as of June 30, 2026.
What is the 52-week low for Conexeu Sciences Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Conexeu Sciences Inc. 52 week low is $4.00 as of June 30, 2026.
What is Conexeu Sciences Inc. stock price today?
Conexeu Sciences Inc. stock price today is $10.60.
What was Conexeu Sciences Inc. stock price yesterday?
Conexeu Sciences Inc. stock price yesterday was $10.24.
What is the Price-to-Book ratio of Conexeu Sciences Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Conexeu Sciences Inc. P/B ratio is 38.0754.
What is the 50-day moving average of Conexeu Sciences Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Conexeu Sciences Inc. 50-day moving average is $12.61.
How many employees does Conexeu Sciences Inc. have?